Spike in ANDA Litigation Drives Operating Company Increase
April 27, 2022
Operating company patent litigation was up in the first quarter of 2022 compared to a slow quarter one year ago, with 274 defendants added (versus 250 in Q1 2021). Nearly all of that increase is attributable to Abbreviated New Drug Applicat...
Read full postJudge Albright, Again the Top Patent Judge, Gets Federal Circuit Pushback over Auto Venue Ruling
April 20, 2022
The top district judge in the first quarter of 2022 was Western District of Texas Judge Alan D. Albright, with 19% of new patent litigation filed in his courtroom. As noted in RPX’s review of the fourth quarter and 2021, Judge Albright ha...
Read full postNPEs Remained Busy Last Quarter Despite a Dip from Q1 2021
April 13, 2022
NPEs added 525 defendants to patent litigation campaigns in the first quarter of 2022—11% below Q1 2021, which at 589 defendants was uncharacteristically active. However, NPEs still had their second busiest first quarter since 2015 and ex...
Read full postSubstantial Amount of Anticounterfeit Litigation Hit the Courts in Late 2021
April 6, 2022
RPX’s latest quarterly review details in part how operating companies added 1,179 defendants to patent litigation campaigns in 2021, a 7.9% decrease from the prior year. However, these operating company data exclude a distinct category of...
Read full postPTAB Petitions Dipped in Q4 and 2021 as Prior Reforms Drew Further Congressional Focus
March 30, 2022
In the fourth quarter of 2021, 339 petitions for America Invents Act (AIA) review were filed with the Patent Trial and Appeal Board (PTAB), including 323 petitions for inter partes review (IPR) and 16 petitions for post-grant review (PGR). ...
Read full postWest Texas Remained the Top Patent Venue in 2021 as Judge Albright Attracted Further Scrutiny
March 23, 2022
The Western District of Texas was the most popular venue for overall patent litigation and NPE litigation in 2021 as a whole and in the fourth quarter, holding second place for operating company litigation in both periods. Delaware took sec...
Read full postIP Edge Sued Around 50 Defendants Every Month in 2021
March 16, 2022
RPX’s Q4 in Review takes a look back at key NPE litigation trends in 2021 and before—including the behavior of patent monetization firm IP Edge LLC, which has long been one of the top patent litigants by defendants added to litigation c...
Read full postAIA Trial Institution Rates Leveled Out in 2021 Amid Continued Debate over NHK-Fintiv
March 10, 2022
The Patent Trial and Appeal Board (PTAB) instituted trial in 61% of the America Invents Act (AIA) review petitions addressed in the fourth quarter of 2021, bringing the year’s institution rate to 58.7%—slightly higher than 2020’s 58.2...
Read full postNPE Litigation Ticked Up Last Quarter as Operating Company Activity Dipped Further
March 2, 2022
NPEs added 551 defendants to patent litigation campaigns in Q4 2021—up slightly from the same quarter last year though down by around 8% compared to Q3 and beating the trailing fourth-quarter 2018-2020 average by 16.1%. Litigation from fi...
Read full postANDA Litigation Remained Clustered in Historic Hotspots Last Year Despite Narrowed Venue Options
February 23, 2022
In 2021, the vast majority of patent litigation targeting generic drugmakers—i.e., cases alleging infringement through the filing of Abbreviated New Drug Applications (ANDAs)—was filed in Delaware and New Jersey, historically the hotspo...
Read full post